Psilocin

Psilocin
Clinical data
Other namesPsilocine; Psilocyn; Psilotsin; 4-Hydroxy-N,N-dimethyltryptamine; 4-Hydroxy-DMT; 4-Hydroxy-N,N-DMT; 4-HO-DMT; 4-OH-DMT; PSOH; PAL-153; PAL153; CX-59; CX59
Routes of
administration
By mouth, intravenous
Drug classSerotonergic psychedelic; Hallucinogen; Serotonin receptor agonist
ATC code
  • None
Legal status
Legal status
Pharmacokinetic data
BioavailabilityOral psilocybin: 52.7 ± 20.4% (as psilocin)
MetabolismLiver, other tissues:
Demethylation and deamination (MAOTooltip monoamine oxidase)
Oxidation (ALDHTooltip aldehyde dehydrogenase)
Glucuronidation (UGTs)
Metabolites• Psilocin-O-glucuronide
• 4-Hydroxy-indole-3-acetaldehyde
• 4-Hydroxyindole-3-acetic acid (4-HIAA)
• 4-Hydroxytryptophol
Elimination half-lifeOral psilocybin: 2.3–3 hours (as psilocin)
IVTooltip Intravenous injection psilocybin: 1.2 hours (as psilocin)
ExcretionUrine (mainly as psilocin-O-glucuronide, 2–4% unchanged)
Identifiers
  • 3-[2-(Dimethylamino)ethyl]-1H-indol-4-ol
CAS Number
PubChem CID
IUPHAR/BPS
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.007.543
Chemical and physical data
FormulaC12H16N2O
Molar mass204.273 g·mol−1
3D model (JSmol)
Melting point173 to 176 °C (343 to 349 °F)
  • CN(C)CCc1c[nH]c2cccc(O)c12
  • InChI=1S/C12H16N2O/c1-14(2)7-6-9-8-13-10-4-3-5-11(15)12(9)10/h3-5,8,13,15H,6-7H2,1-2H3 Y
  • Key:SPCIYGNTAMCTRO-UHFFFAOYSA-N Y
  (verify)

Psilocin, also known as 4-hydroxy-N,N-dimethyltryptamine (4-HO-DMT), is a substituted tryptamine alkaloid and a serotonergic psychedelic. It is present in most psychedelic mushrooms together with its phosphorylated counterpart psilocybin. Psilocybin, as well as synthetic esters such as 4-AcO-DMT (psilacetin; O-acetylpsilocin) and 4-PrO-DMT (O-propionylpsilocin), are prodrugs of psilocin.

Acting on the serotonin 5-HT2A receptors, psilocin's psychedelic effects are directly correlated with the drug's occupancy at these receptor sites. It also interacts with other serotonin receptors and targets. The subjective mind-altering effects of psilocin are highly variable in their qualitative nature but resemble those of lysergic acid diethylamide (LSD) and N,N-dimethyltryptamine (DMT).

Psilocin is a Schedule I drug under the Convention on Psychotropic Substances.